Zostergalen

Zostergalen (Brivudine) is an oral antiviral medication used to treat shingles (herpes zoster). It helps reduce the duration and severity of symptoms when taken early. This EU-sourced treatment is designed for adults with active infections. Seek medical advice for suitability.

Zostergalen (Brivudine) is prescribed to shorten the duration of shingles outbreaks by slowing viral replication. It is most effective when started within 72 hours of rash onset. The medication belongs to the antiviral class and targets the varicella-zoster virus. Patients often ask what is Brivudine used for, and it is specifically indicated for herpes zoster in immunocompetent adults.

Users may experience relief from pain and discomfort associated with shingles as the medication takes effect. Common effects include reduced rash progression and faster healing of blisters. Some individuals report mild gastrointestinal effects during treatment. Effects vary by individual response and timing of administration.

Store Zostergalen in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. Do not use if the packaging is damaged or the expiry date has passed. Consult a healthcare provider before starting treatment, especially if you have kidney or liver conditions.

Brivudine may interact with certain medications, including immunosuppressants and other antivirals. Alcohol consumption during treatment may reduce effectiveness or increase side effects. Always inform your doctor about all prescription, over-the-counter, and herbal products you are using. Monitor for unusual reactions when combining therapies.